Ardelyx, Inc. (ARDX)
3.775
+0.06
(+1.75%)
USD |
NASDAQ |
Sep 04, 16:00
3.775
0.00 (0.00%)
After-Hours: 20:00
Ardelyx Cash and Short Term Investments (Annual) : 264.69M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 264.69M |
| December 31, 2024 | 250.10M |
| December 31, 2023 | 184.30M |
| December 31, 2022 | 123.91M |
| December 31, 2021 | 116.69M |
| December 31, 2020 | 186.48M |
| December 31, 2019 | 247.51M |
| Date | Value |
|---|---|
| December 31, 2018 | 168.09M |
| December 31, 2017 | 133.98M |
| December 31, 2016 | 200.82M |
| December 31, 2015 | 107.00M |
| December 31, 2014 | 107.29M |
| December 31, 2013 | 34.44M |
| December 31, 2012 | 32.90M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| REGENXBIO, Inc. | 230.07M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |
| Savara, Inc. | 235.70M |